Endothelial dysfunction biomarker, endothelial cell-specific molecule-1, and pediatric metabolic syndrome

Halici I., Palabiyik S. S., Guducu-Tufekci F., Ozbek-Bilgin A., CAYİR A.

PEDIATRICS INTERNATIONAL, vol.58, no.11, pp.1124-1129, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 58 Issue: 11
  • Publication Date: 2016
  • Doi Number: 10.1111/ped.12989
  • Journal Name: PEDIATRICS INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1124-1129
  • Erzincan Binali Yildirim University Affiliated: No

Abstract

BackgroundThe aim of this study was to compare serum endothelial cell-specific molecule-1 (endocan) in pediatric patients with metabolic syndrome (MetS) and in healthy children, and to determine whether it can be used as an indicator of endothelium damage-induced complications in pediatric MetS patients.